In General

Here is where we will share the most updated industry news and patient stories with you.

June, 2020


  • Proton Beam Therapy is well known to have the advantage of reducing the irradiated volume and dose to surrounding normal tissue, in patients with lung cancer, compared with SBRT. A nationwide retrospective study from Japan, published in International Journal of Radiation Oncology, proved that proton beam therapy yielded acceptable survival rates, with a low rate of toxicities for Stage 1 Non-Small Cell Lung Cancer.



  • The Annual Report to the Nation on the Status of Cancer published by the American Cancer Society states that “Although overall cancer death rates continue to decline, incidence rates are leveling off among males and are increasing slightly among females. These trends reflect population changes in cancer risk factors, screening test use, diagnostic practices, and treatment advances.”


Subscribe ProTom for more information.